Skip to main navigation Skip to search Skip to main content

Coupling deep phenotypic quantification with next-generation phenotyping for 192 individuals with germline histonopathies

  • Emily E. Lubin
  • , Elizabeth M. Gonzalez
  • , Annabel K. Sangree
  • , Emily L. Durham
  • , Hannah Klinkhammer
  • , Jing Mei Li
  • , Sarina M. Smith
  • , Dana E. Layo-Carris
  • , Kelly J. Clark
  • , Ashley J. Melendez-Perez
  • , Xiao Min Wang
  • , Rajesh Angireddy
  • , Erin E. Weiss
  • , Tahsin Stefan Barakat
  • , Sandra Mercier
  • , Benjamin Cogné
  • , Saskia Koene
  • , Yvonne Hilhorst-Hofstee
  • , Malgorzata Rydzanicz
  • , Rafal Ploski
  • María de los Ángeles Gómez Cano, María Palomares-Bralo, Tania Barragán Arévalo, Tiong Yang Tan, Lyndon Gallacher, Suzanne P. MacFarland, Rebecca C. Ahrens-Nicklas, Tomoki T. Nomakuchi, Elizabeth J.K. Bhoj*
*Corresponding author for this work
  • UPenn School of Medicine
  • Children's Hospital of Philadelphia
  • The TBCK Foundation
  • University Hospital Bonn
  • CHU de Nantes
  • CNRS
  • Leiden University
  • Medical University of Warsaw
  • INGEMM-Idipaz
  • Centro de Investigación Biomédica en Red (CIBER)
  • Hospital Infantil de Mexico Federico Gomez
  • Murdoch Children's Research Institute
  • University of Melbourne

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
36 Downloads (Pure)

Abstract

Mendelian histonopathies are rare neurodevelopmental disorders (NDDs) caused by germline variants in histone-encoding genes. Here, we perform a more expansive pan-histonopathy interrogation than previously possible. We analyze data from 192 individuals affected by histonopathies. This analysis includes representation of the 185 published individuals with HIST1H1E syndrome, Bryant-Li-Bhoj syndrome, and Tessadori-Bicknell-van Haaften NDD; as well as from seven unpublished individuals, five of whom harbor variants in genes not previously associated with disease (HIST1H2AL/H2AC16, H2AFZ/H2AZ1, HIST1H3D/H3C4, and HIST3H3/H3-4). By intersecting clinician-reported phenotypic data with next-generation phenotyping of published 2D facial photographs (n = 98), we sought to address the lack of established craniofacial gestalts or characteristic phenotypic patterns for this community. While these analyses may suggest a histone core versus linker protein basis of delineation, they more strikingly highlight data gaps that confound the identification of phenotypic patterns at this time. Based on this, we developed an updated standardized clinical survey, which allowed us to identify the second known individual with a germline histonopathy and a cancer diagnosis. Notably, the community-wide cancer incidence is currently 1%, which falls below the recommended 5% cut off for routine surveillance. Ultimately, this work highlights the ways in which histonopathy-associated phenotypes change throughout the lifespan, necessitating longitudinal re-evaluation; that every identified individual shapes our understanding of these syndromes in a way that improves care for this community; and the value of ongoing translational work to address the outstanding question of cancer predisposition for individuals living with germline histonopathies.

Original languageEnglish
Article number100440
JournalHuman Genetics and Genomics Advances
Volume6
Issue number3
DOIs
Publication statusPublished - 10 Jul 2025

Bibliographical note

Publisher Copyright: © 2025 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Coupling deep phenotypic quantification with next-generation phenotyping for 192 individuals with germline histonopathies'. Together they form a unique fingerprint.

Cite this